Bristol Myers Squibb (CELG-RI) Change in Taxes (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has reported Change in Taxes for 18 consecutive years, with -$522.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Taxes rose 15.94% year-over-year to -$522.0 million; the TTM figure through Jun 2026 stood at $228.0 million (up 128.72% YoY), while the FY2025 annual figure was -$4.0 million, up 99.68% from the prior year.
• Change in Taxes slipped to -$522.0 million in Q2 2026 per CELG-RI's latest filing, from $187.0 million in the prior quarter.
• Across five years, Change in Taxes topped out at $1.0 billion in Q4 2023 and bottomed at -$2.1 billion in Q2 2023.
• Historically, Change in Taxes has averaged -$201.4 million across 5 years, with a median of -$135.0 million in 2025.
• Annual changes were most pronounced in 2023 — Change in Taxes tumbled 786.67% — and 2025, when it surged 354.89%.
• Bristol Myers Squibb's Change in Taxes stood at -$1.1 billion in 2022, then jumped by 193.8% to $1.0 billion in 2023, then slumped by 88.41% to $121.0 million in 2024, then plunged by 367.77% to -$324.0 million in 2025, then sank by 61.11% to -$522.0 million in 2026.
• Business Quant data shows CELG-RI's Change in Taxes at -$522.0 million in Q2 2026, $187.0 million in Q1 2026, and -$324.0 million in Q4 2025.